These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Dalakas MC. Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756 [Abstract] [Full Text] [Related]
25. [Dysimmune and inflammatory myopathies]. Authier FJ. Rev Prat; 2008 Dec 31; 58(20):2253-60. PubMed ID: 19209656 [Abstract] [Full Text] [Related]
26. Inclusion body myositis. Chou SM. Baillieres Clin Neurol; 1993 Nov 31; 2(3):557-77. PubMed ID: 8156143 [Abstract] [Full Text] [Related]
27. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Arthritis Rheum; 1997 May 31; 40(5):865-74. PubMed ID: 9153548 [Abstract] [Full Text] [Related]
28. [Myositides]. Bornemann A, Heitmann S, Lindner A. Pathologe; 2009 Sep 31; 30(5):352-6. PubMed ID: 19618187 [Abstract] [Full Text] [Related]
30. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis). Pongratz D. J Neurol; 2006 Sep 31; 253 Suppl 5():V64-5. PubMed ID: 16998756 [Abstract] [Full Text] [Related]
31. An overview of polymyositis and dermatomyositis. Findlay AR, Goyal NA, Mozaffar T. Muscle Nerve; 2015 May 31; 51(5):638-56. PubMed ID: 25641317 [Abstract] [Full Text] [Related]
32. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. Illa I, Gallardo E, Gimeno R, Serrano C, Ferrer I, Juárez C. Am J Pathol; 1997 Jul 31; 151(1):81-8. PubMed ID: 9212734 [Abstract] [Full Text] [Related]
33. Can tissue transglutaminase be a marker of idiopathic inflammatory myopathies? Gendek EG, Kedziora J, Gendek-Kubiak H. Immunol Lett; 2005 Mar 15; 97(2):245-9. PubMed ID: 15752564 [Abstract] [Full Text] [Related]
34. Classification, diagnosis, and management of idiopathic inflammatory myopathies. Lazarou IN, Guerne PA. J Rheumatol; 2013 May 15; 40(5):550-64. PubMed ID: 23504386 [Abstract] [Full Text] [Related]
37. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Chahin N, Engel AG. Neurology; 2008 Feb 05; 70(6):418-24. PubMed ID: 17881720 [Abstract] [Full Text] [Related]
38. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles]. Figarella-Branger D, Pellissier JF, Pouget J, Calore EE, Azulay JP, Desnuelle C, Serratrice G. Rev Neurol (Paris); 1992 Feb 05; 148(4):281-90. PubMed ID: 1332175 [Abstract] [Full Text] [Related]
39. Inflammatory myopathies: Part 1. Mastaglia FL, Ojeda VJ. Ann Neurol; 1985 Mar 05; 17(3):215-27. PubMed ID: 2986525 [Abstract] [Full Text] [Related]
40. Acquired immune and inflammatory myopathies: pathologic classification. Pestronk A. Curr Opin Rheumatol; 2011 Nov 05; 23(6):595-604. PubMed ID: 21934500 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]